The global active humidifier devices market, a key player in respiratory care, is expected to experience a modest decline in the coming years. Recent projections indicate that the market, valued at USD 1,264.4 million in 2023, is on track for a slight decrease, with a projected value of USD 1,206.9 million by 2033, reflecting a negative compound annual growth rate (CAGR) of -0.5%.
Historically, the active humidifier devices market has seen significant growth, particularly during the COVID-19 pandemic, where it achieved an impressive CAGR of 28.7%. The surge in demand was driven by the critical role these devices played in respiratory care, especially for patients on mechanical ventilation. Active humidifiers, which provide humidified air to support respiratory function, became indispensable in improving patient outcomes during the pandemic.
In response to the urgent need for respiratory assistance during COVID-19, manufacturers rapidly introduced a variety of innovative solutions. These devices proved to be lifesaving, enhancing the quality of care for countless patients. However, as the pandemic subsided and the global health landscape stabilized, the demand for active humidifier devices has decreased, leading to a gradual decline in market growth.
In addition to reduced demand, the market faces challenges related to safety concerns. Potential risks associated with active humidifiers, such as the buildup of water in tubing circuits and infection risks, have prompted manufacturers to explore safer and more efficient alternatives. As the industry shifts its focus towards innovation, there is hope for advancements that will address these issues while improving patient safety.
Despite the short-term market contraction, there is optimism for a future recovery driven by technological innovations. As manufacturers continue to develop next-generation respiratory care devices, the global active humidifier devices market may see renewed growth in the long term.
Regional Insights
- North America is set to maintain a leading position, with an estimated market share of over 29.4% in 2023. The United States alone is projected to capture a significant share of above 27.8%.
- Europe follows, with an anticipated value share of over 12.2% in 2023. Germany, in particular, holds a notable 4% share of the global market.
- Japan is expected to contribute a value share exceeding 9.7%.
- Conversely, Australia and India are projected to experience negative growth rates of -1.3% and -2.8%, respectively.
- China is expected to exhibit a modest CAGR of 1.5% from 2023 to 2033.
- The United Kingdom is anticipated to see a minimal growth rate of 0.1% CAGR.
Product and Application Insights
- Electronic humidifiers are expected to dominate, holding a projected value share of 55.79%.
- Adults are the primary users, accounting for 87.99% of the market.
- The invasive ventilation segment is a major contributor, representing 47% of market growth.
- Hospitals are the largest end-users, forming 64.5% of the market share.
Heightened Market Interest: Our Complete Report Delivers Extensive Analysis and Trends!
Historical Developments and Long-term Strategies
Active humidifier device manufacturers have faced a decline from the historical high growth driven by COVID-19. For instance, Hamilton Medical’s introduction of the H900 active humidifier in 2016 marked a significant advancement in the industry.
To navigate current challenges, key players are focusing on strategic collaborations, partnerships, and acquisitions. Recent notable developments include:
- Vadi Medical Technology’s expansion of its product line with the VH3000-220 Humidifier in January 2021.
- Intersurgical Ltd.’s establishment of a new office in Canada to enhance product availability.
- WILAmed GmbH’s launch of the AIRcon Gen2 Respiratory Humidifier in 2019.
Market Dominance by Key Players in the Market:
- Fisher & Paykel Healthcare Limited
- Koninklijke Philips N.V.(Philips Respironics)
- Vapotherm
- Teleflex Corporation
- ResMed Corporation
- VINCENT MEDICAL HOLDINGS LIMITED
- Armstrong Medical (an Eakin Company)
- Breas Medical AB (Subsidiary of Fosun Pharma)
- BMC Medical Co., Ltd
- Hamilton Medical AG
- SunMed
- WILAmed GmbH
- Flexicare (Group) Limited
- Penlon Limited
- DEAS S.R.L.
- Intersurgical Ltd
- Beijing Aeonmed Co., Ltd.
- Shenyang RMS MEDICAL TECH CO., LTD
- GaleMed Corporation
- Vadi Medical Technology Co, Ltd.
Active Humidifier Devices by Category:
Product Type:
- Heated/electronic Humidifiers
- Bubble Humidifiers
- Accessories
Age Group:
- Adult
- Pediatric
- Neonates
Application:
- Invasive Ventilation
- Non-invasive Ventilation
- nCPAP (Nasal Continuous Positive Airway Pressure)
- Bubble CPAP (Bubble Continuous Positive Airway Pressure)
- High Flow Oxygen Therapy
End User:
- Hospitals
- Less than 100 Beds
- 100-300 Beds
- 300-500 Beds
- 500 Beds and More
- Ambulatory Surgical Centers
- Sleep Centers
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube